INTEGRATED SERUM PROTEOMIC AND METABOLOMIC PROFILES IN SYSTEMIC SCLEROSIS PATIENTS CHARACTERIZE NEW BIOMARKERS ASSOCIATED TO RELEVANT PATHOLOGICAL FEATURES

被引：0
|
作者：
Sanchez-Pareja, I. [1 ]
Ortega Castro, R. [1 ]
Pilar, F. U. [1 ]
Cerdo, T. [1 ]
Munoz-Barrera, L. [1 ]
Abalos-Aguilera, M. C. [1 ]
Merlo, C. [1 ]
Ortiz Buitrago, P. [1 ]
Barbarroja Puerto, N. [2 ]
Collantes Estevez, E. [1 ]
Aguirre, M. A. [1 ]
Perez-Sanchez, C. [3 ]
Lopez-Pedrera, C. [1 ]
机构：
[1] Univ Cordoba, Reina Sofia Hosp, IMIBIC, Rheumatol, Cordoba, Spain
[2] Univ Cordoba, Reina Sofia Hosp, MIBIC, Med & Surg Sci, Cordoba, Spain
[3] Univ Cordoba, Reina Sofia Hosp, IMIBIC, Cell Biol Physiol & Immunol, Cordoba, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Biomarkers; -Omics; Systemic sclerosis;
D O I：
10.1136/annrheumdis-2023-eular.3648
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0623
引用
收藏
页码：585 / 585
页数：1
相关论文
共 7 条
  • [1] SERUM PROTEOMIC BIOMARKERS DEFINE PATIENTS WITH SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE
    De Santis, M.
    Isailovic, N.
    Ceribelli, A.
    Motta, F.
    Vecellio, M.
    Selmi, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 152 - 152
  • [2] Proteomic aptamer analysis reveals serum biomarkers associated with disease mechanisms and phenotypes of systemic sclerosis
    Motta, Francesca
    Tonutti, Antonio
    Isailovic, Natasa
    Ceribelli, Angela
    Costanzo, Giovanni
    Rodolfi, Stefano
    Selmi, Carlo
    De Santis, Maria
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] A LARGE-SCALE PRTEOMIC APPROACH IDENTIFIED NEW SERUM BIOMARKERS ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Meroni, M.
    De Santis, M.
    Generali, E.
    Ceribelli, A.
    Isailovic, N.
    Caprioli, M.
    Guidelli, G. M.
    Selmi, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (01) : S101 - S101
  • [4] Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc
    Bellocchi, Chiara
    Assassi, Shervin
    Lyons, Marka
    Marchini, Maurizio
    Mohan, Chandra
    Santaniello, Alessandro
    Beretta, Lorenzo
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [5] Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc
    Chiara Bellocchi
    Shervin Assassi
    Marka Lyons
    Maurizio Marchini
    Chandra Mohan
    Alessandro Santaniello
    Lorenzo Beretta
    [J]. Arthritis Research & Therapy, 25
  • [6] Interleukin-6 serum levels are associated with disease features and cardiovascular risk in patients with systemic sclerosis
    Ibrahim-Achi, Z.
    de Vera-Gonzalez, A.
    Gonzalez-Delgado, A.
    Lopez-Mejias, R.
    Gonzalez-Gay, M. A.
    Ferraz-Amaro, I.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (08) : 1564 - 1570
  • [7] High serum C-X-C motif chemokine ligand 10 (CXCL10) levels may be associated with new onset interstitial lung disease in patients with systemic sclerosis: evidence from observational, clinical, transcriptomic and in vitro studies
    Al-Adwi, Yehya
    Atzeni, Isabella Maria
    Doornbos-van der Meer, Berber
    van der Leij, Marcel John
    Varkevisser, Rita Delphine Maiko
    Stel, Alja
    Timens, Wim
    Gan, Christiaan Tji
    van Goor, Harry
    Westra, Johanna
    Mulder, Douwe Johannes
    [J]. EBIOMEDICINE, 2023, 98
1